PreveCeutical Medical Inc
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddict… Read more
PreveCeutical Medical Inc (PRVCF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.070x
Based on the latest financial reports, PreveCeutical Medical Inc (PRVCF) has a cash flow conversion efficiency ratio of 0.070x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-520.46K) by net assets ($-7.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PreveCeutical Medical Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how PreveCeutical Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PreveCeutical Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PreveCeutical Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pan American Energy Corp
OTCQB:PAANF
|
-0.059x |
|
AVENSIA AB SK -15
F:5IY
|
N/A |
|
Samyoung S&C Co. Ltd.
KQ:361670
|
-0.023x |
|
Honkarakenne Oyj B
HE:HONBS
|
-0.200x |
|
REVOLVE RENEW.POWER CORP.
F:PM7
|
N/A |
|
Cordlife Group Limited
PINK:CLIFF
|
0.013x |
|
Xelpmoc Design And Tech Limited
NSE:XELPMOC
|
-0.049x |
|
Jiangsu Zitian Media Technology Co Ltd
SHE:300280
|
0.086x |
Annual Cash Flow Conversion Efficiency for PreveCeutical Medical Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of PreveCeutical Medical Inc from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-6.64 Million | $-426.69K | 0.064x | +25.09% |
| 2023-12-31 | $-5.78 Million | $-296.97K | 0.051x | -47.18% |
| 2022-12-31 | $-4.64 Million | $-450.99K | 0.097x | -6.35% |
| 2021-12-31 | $-4.10 Million | $-426.39K | 0.104x | +679.67% |
| 2020-12-31 | $-3.60 Million | $64.59K | -0.018x | -108.09% |
| 2019-12-31 | $-4.49 Million | $-993.94K | 0.222x | -93.32% |
| 2018-12-31 | $-2.29 Million | $-7.57 Million | 3.314x | -73.46% |
| 2017-12-31 | $-344.34K | $-4.30 Million | 12.485x | +181.02% |
| 2016-12-31 | $-296.06K | $-1.32 Million | 4.443x | +989.51% |
| 2016-07-31 | $112.52K | $-56.20K | -0.499x | +97.36% |
| 2015-12-31 | $37.29K | $-706.03K | -18.932x | -- |